Update on Management of LR-MDS from ASH23

2) This program is intended for #HCPs & is supported by an independent educational grant from Bristol Myers Squibb. Faculty disclosures & statement of accreditation at https://t.co/8oShcATovC. Earn 0.75hr ๐Ÿ†“ CE/#CME when u follow this ๐Ÿงต!#FOAMed #MedTwitter...

UPDATE FROM SOHO23: New Data on the Management of LR-MDS

1b) @AmyDeZern is Director, Bone Marrow Failure & #MDS Program at #Hopkins and has expertise in #aplastic #anemia, #myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria #PNH, acute myeloid #leukemia #AML, & bone marrow transplantation #BMT....

Advances in the Management of LR-MDS: ASCO23 Update

1b) Our content expert for this program is Amer Zeidan MBBS,MHS @Dr_AmerZeidan, Associate Prof, Asst Director CTO, Director #Heme early phase/#Leuksm research, @Yale. @Dr_AmerZeidan is widely published in #MDSsm. pic.twitter.com/rKIiVWNbEI— @onc_ce (@onc_ce)...